Increased plasma levels of VWF antigen (VWF:Ag) have been found in GBM patients, with higher VWF plasma levels correlating with shorter survival, rendering VWF:Ag levels a putative circulating prognostic factor [11]. The gene discussed is VWF; the disease is glioblastoma.